ESR2 and neoplasm: It is known that ERα promotes proliferation, inflammation, and migration, whereas ERβ is considered antiproliferative and tumor-suppressive, and the loss of it has been associated with the progression to castration resistance (27) However, it has been considered that activation of ERβ increase non-phosphorylated β-catenin which promotes migration and invasion therefore it is currently consider as a controversy.